ENDRA Life Sciences Overview
- Year Founded
-
2007
- Status
-
Public
- Employees
-
11
- Stock Symbol
-
NDRA
- Investments
-
1
- Share Price
-
$3.70
- (As of Thursday Closing)
ENDRA Life Sciences General Information
Description
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.
Contact Information
Website
www.endrainc.comCorporate Office
- 3600 Green Court
- Suite 350
- Ann Arbor, MI 48105-1570
- United States
Corporate Office
- 3600 Green Court
- Suite 350
- Ann Arbor, MI 48105-1570
- United States
ENDRA Life Sciences Stock Performance
As of 19-Nov-2026, ENDRA Life Sciences’s stock price is $3.70. Its current market cap is $5.55M with 1.5M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.70 | $4.04 | $2.96 - $6.75 | $5.55M | 1.5M | 29.4K | -$5.25 |
ENDRA Life Sciences Financials Summary
As of 30-Sep-2026, ENDRA Life Sciences has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 7,628 | 5,015 | (1,147) | 15,023 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (5,691) | (6,870) | (11,302) | (9,785) |
| Net Income | (5,849) | (7,027) | (11,508) | (10,060) |
| Total Assets | 6,723 | 3,854 | 4,452 | 6,754 |
| Total Debt | 397 | 492 | 584 | 394 |
ENDRA Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
ENDRA Life Sciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
ENDRA Life Sciences Comparisons
Industry
Financing
Details
ENDRA Life Sciences Competitors (18)
One of ENDRA Life Sciences’s 18 competitors is SigTuple, a Venture Capital-Backed company based in Bengaluru, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| SigTuple | Venture Capital-Backed | Bengaluru, India | ||||
| TeraRecon | Formerly VC-backed | Durham, NC | ||||
| Rivanna (Diagnostic Equipment) | Venture Capital-Backed | Charlottesville, VA | ||||
| Niramai | Venture Capital-Backed | Bangalore, India | ||||
| iCAD | Corporate Backed or Acquired | Nashua, NH |
ENDRA Life Sciences Patents
ENDRA Life Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11994549-B1 | Method and system to determine radio frequency antenna electromagnetic field spatial distribution | Active | 31-Dec-2023 | ||
| WO-2025145171-A1 | Method and system to determine radio frequency antenna electromagnetic field spatial distribution | Inactive | 31-Dec-2023 | ||
| US-20250213119-A1 | Method and system for enhancing rf energy delivery during thermoacoustic imaging | Inactive | 30-Dec-2023 | ||
| WO-2025145136-A1 | Method and system for enhancing rf energy delivery during thermoacoustic imaging | Inactive | 30-Dec-2023 | ||
| US-12350015-B2 | Radio frequency applicator | Active | 10-Nov-2023 | A61B5/0093 |
ENDRA Life Sciences Signals
ENDRA Life Sciences Acquisitions (1)
ENDRA Life Sciences’s most recent deal was a Reverse Merger with Noble Africa. The deal was made on 25-Jun-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Noble Africa | 25-Jun-2026 | Reverse Merger | Holding Companies |
ENDRA Life Sciences ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
36.29 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
ENDRA Life Sciences FAQs
-
When was ENDRA Life Sciences founded?
ENDRA Life Sciences was founded in 2007.
-
Where is ENDRA Life Sciences headquartered?
ENDRA Life Sciences is headquartered in Ann Arbor, MI.
-
What is the size of ENDRA Life Sciences?
ENDRA Life Sciences has 11 total employees.
-
What industry is ENDRA Life Sciences in?
ENDRA Life Sciences’s primary industry is Diagnostic Equipment.
-
Is ENDRA Life Sciences a private or public company?
ENDRA Life Sciences is a Public company.
-
What is ENDRA Life Sciences’s stock symbol?
The ticker symbol for ENDRA Life Sciences is NDRA.
-
What is the current stock price of ENDRA Life Sciences?
As of 19-Nov-2026 the stock price of ENDRA Life Sciences is $3.70.
-
What is the current market cap of ENDRA Life Sciences?
The current market capitalization of ENDRA Life Sciences is $5.55M.
-
Who are ENDRA Life Sciences’s competitors?
SigTuple, TeraRecon, Rivanna (Diagnostic Equipment), Niramai, and iCAD are some of the 18 competitors of ENDRA Life Sciences.
-
What is ENDRA Life Sciences’s annual earnings per share (EPS)?
ENDRA Life Sciences’s EPS for 12 months was -$5.25.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process